Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Dec 12, 2013
Distillery Therapeutics
Indication: Cardiovascular disease
...significant comorbidities. SciBX 6(47); doi:10.1038/scibx.2013.1350 Published online Dec. 12, 2013 Patent application filed; licensed by
Tyrosine Pharma
...
Read More
BioCentury
|
Dec 9, 2013
Company News
Tyrosine Pharma management update
Tyrosine Pharma Inc.
, Albuquerque, N.M. Business: Neurology Hired: Wayne Laslie as president and CEO WIR Staff Neurology...
Read More
Items per page:
10
1 - 2 of 2
BioCentury
|
Dec 12, 2013
Distillery Therapeutics
Indication: Cardiovascular disease
...significant comorbidities. SciBX 6(47); doi:10.1038/scibx.2013.1350 Published online Dec. 12, 2013 Patent application filed; licensed by
Tyrosine Pharma
...
Read More
BioCentury
|
Dec 9, 2013
Company News
Tyrosine Pharma management update
Tyrosine Pharma Inc.
, Albuquerque, N.M. Business: Neurology Hired: Wayne Laslie as president and CEO WIR Staff Neurology...
Read More
Items per page:
10
1 - 2 of 2
Previous page
Next page